| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Neoplasms, Experimental | 21 | 2018 | 246 | 2.820 |
Why?
|
| Mammary Glands, Animal | 18 | 2018 | 477 | 2.310 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2018 | 792 | 1.110 |
Why?
|
| Breast Neoplasms | 16 | 2018 | 2763 | 1.020 |
Why?
|
| Precancerous Conditions | 6 | 2012 | 288 | 1.020 |
Why?
|
| Carcinogens | 8 | 2009 | 160 | 0.910 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2011 | 141 | 0.860 |
Why?
|
| Progesterone | 7 | 2005 | 631 | 0.680 |
Why?
|
| Neoplastic Stem Cells | 5 | 2016 | 352 | 0.640 |
Why?
|
| Neoplasm Transplantation | 6 | 2014 | 399 | 0.640 |
Why?
|
| Estrogens | 5 | 2005 | 522 | 0.610 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2012 | 74 | 0.600 |
Why?
|
| Mammary Glands, Human | 4 | 2012 | 83 | 0.580 |
Why?
|
| Stromal Cells | 3 | 2014 | 313 | 0.500 |
Why?
|
| Mice | 38 | 2019 | 18909 | 0.490 |
Why?
|
| Mice, Inbred BALB C | 14 | 2018 | 1079 | 0.490 |
Why?
|
| Tamoxifen | 4 | 2018 | 377 | 0.450 |
Why?
|
| Estrogen Receptor alpha | 5 | 2013 | 474 | 0.440 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 7 | 2009 | 55 | 0.430 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2014 | 31 | 0.430 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 2122 | 0.430 |
Why?
|
| Morphogenesis | 2 | 2012 | 215 | 0.420 |
Why?
|
| Tetrahydronaphthalenes | 2 | 2012 | 29 | 0.410 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 37 | 0.390 |
Why?
|
| Epithelial Cells | 10 | 2013 | 941 | 0.390 |
Why?
|
| Animals | 43 | 2019 | 36388 | 0.390 |
Why?
|
| Proteoglycans | 1 | 2012 | 94 | 0.380 |
Why?
|
| Laminin | 1 | 2012 | 71 | 0.380 |
Why?
|
| Antigens, CD | 1 | 2014 | 452 | 0.380 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 54 | 0.370 |
Why?
|
| Glycoproteins | 1 | 2014 | 379 | 0.370 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 135 | 0.360 |
Why?
|
| Aneuploidy | 4 | 2013 | 145 | 0.360 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 2013 | 107 | 0.340 |
Why?
|
| Collagen | 1 | 2012 | 334 | 0.340 |
Why?
|
| Peptides | 1 | 2014 | 859 | 0.340 |
Why?
|
| Models, Biological | 2 | 2012 | 1532 | 0.310 |
Why?
|
| Anticarcinogenic Agents | 2 | 2009 | 54 | 0.310 |
Why?
|
| Chromosomal Instability | 3 | 2008 | 63 | 0.310 |
Why?
|
| Estradiol | 3 | 2014 | 552 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 644 | 0.290 |
Why?
|
| Quinazolines | 1 | 2009 | 184 | 0.280 |
Why?
|
| Breast | 3 | 2007 | 218 | 0.280 |
Why?
|
| Sulfonamides | 1 | 2009 | 286 | 0.260 |
Why?
|
| Receptors, Estrogen | 5 | 2018 | 828 | 0.260 |
Why?
|
| Genes, p53 | 3 | 2007 | 234 | 0.260 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 4777 | 0.260 |
Why?
|
| Cell Growth Processes | 5 | 2013 | 69 | 0.260 |
Why?
|
| Pyrazoles | 1 | 2009 | 328 | 0.250 |
Why?
|
| Mice, Inbred NOD | 4 | 2016 | 318 | 0.250 |
Why?
|
| Mice, SCID | 4 | 2016 | 613 | 0.240 |
Why?
|
| Hyperplasia | 5 | 2008 | 203 | 0.230 |
Why?
|
| Female | 40 | 2021 | 71684 | 0.220 |
Why?
|
| Cell Cycle Proteins | 7 | 2008 | 697 | 0.220 |
Why?
|
| Cell Cycle | 3 | 2014 | 626 | 0.210 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2003 | 101 | 0.200 |
Why?
|
| Carcinogens, Environmental | 1 | 2002 | 15 | 0.190 |
Why?
|
| Progestins | 1 | 2002 | 53 | 0.190 |
Why?
|
| Separase | 3 | 2013 | 29 | 0.180 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2018 | 271 | 0.180 |
Why?
|
| Founder Effect | 1 | 2021 | 34 | 0.180 |
Why?
|
| Hydatidiform Mole | 1 | 2021 | 20 | 0.180 |
Why?
|
| Injections, Intralesional | 2 | 2019 | 51 | 0.180 |
Why?
|
| Rats | 8 | 2010 | 3883 | 0.170 |
Why?
|
| Cell Division | 5 | 2004 | 774 | 0.160 |
Why?
|
| Graft Survival | 2 | 2012 | 558 | 0.160 |
Why?
|
| Mice, Transgenic | 7 | 2015 | 2526 | 0.160 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2019 | 47 | 0.160 |
Why?
|
| Cyclins | 3 | 2004 | 104 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 5 | 2012 | 260 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1850 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 619 | 0.140 |
Why?
|
| Humans | 27 | 2021 | 133943 | 0.140 |
Why?
|
| Epithelium | 2 | 2012 | 370 | 0.130 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2016 | 12 | 0.130 |
Why?
|
| Autocrine Communication | 1 | 2016 | 29 | 0.130 |
Why?
|
| Mice, Knockout | 6 | 2009 | 3981 | 0.130 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2016 | 36 | 0.130 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 50 | 0.130 |
Why?
|
| Endopeptidases | 2 | 2008 | 118 | 0.130 |
Why?
|
| Cell Line, Tumor | 7 | 2016 | 3751 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 142 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2010 | 352 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 492 | 0.110 |
Why?
|
| Cell Differentiation | 3 | 2012 | 2025 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 821 | 0.110 |
Why?
|
| AC133 Antigen | 1 | 2014 | 37 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 221 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 749 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 159 | 0.110 |
Why?
|
| Neoplasms | 2 | 2019 | 3027 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2007 | 510 | 0.110 |
Why?
|
| Disease Progression | 3 | 2013 | 2242 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 132 | 0.110 |
Why?
|
| Leukocyte Common Antigens | 1 | 2014 | 93 | 0.110 |
Why?
|
| Pregnancy | 8 | 2021 | 7522 | 0.110 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 106 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 92 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 889 | 0.110 |
Why?
|
| Culture Media | 1 | 2014 | 184 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2014 | 246 | 0.110 |
Why?
|
| 14-3-3 Proteins | 1 | 2013 | 56 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2013 | 1134 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2014 | 342 | 0.100 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2013 | 47 | 0.100 |
Why?
|
| Heterozygote | 2 | 2021 | 718 | 0.100 |
Why?
|
| Antigens, CD19 | 1 | 2014 | 181 | 0.100 |
Why?
|
| Cell Size | 1 | 2013 | 89 | 0.100 |
Why?
|
| Nicotinic Acids | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cell Proliferation | 5 | 2016 | 2539 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 234 | 0.100 |
Why?
|
| Apoptosis | 4 | 2014 | 1930 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 56 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2014 | 90 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 362 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 58 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2012 | 46 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 1761 | 0.090 |
Why?
|
| Fetal Blood | 1 | 2012 | 179 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 29 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 283 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 1127 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3167 | 0.090 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2010 | 47 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 667 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 305 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 321 | 0.080 |
Why?
|
| Parity | 1 | 2010 | 86 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 746 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 2161 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2010 | 150 | 0.080 |
Why?
|
| Sarcoma | 1 | 2012 | 210 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 844 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 2940 | 0.080 |
Why?
|
| Celecoxib | 1 | 2009 | 35 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 1070 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2009 | 73 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2009 | 57 | 0.080 |
Why?
|
| Melanoma | 1 | 2016 | 975 | 0.070 |
Why?
|
| Chloroquine | 1 | 2007 | 32 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 563 | 0.070 |
Why?
|
| Stem Cells | 1 | 2013 | 753 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2007 | 74 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 303 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2019 | 869 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 147 | 0.070 |
Why?
|
| Lactation | 2 | 2005 | 199 | 0.070 |
Why?
|
| Centrosome | 2 | 2007 | 22 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1623 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6297 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 6590 | 0.070 |
Why?
|
| Incidence | 3 | 2013 | 3402 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2004 | 62 | 0.070 |
Why?
|
| Phenotype | 3 | 2013 | 4548 | 0.060 |
Why?
|
| Risk | 1 | 2008 | 832 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2018 | 777 | 0.060 |
Why?
|
| Mad2 Proteins | 1 | 2004 | 9 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 169 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 12 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 609 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2013 | 836 | 0.060 |
Why?
|
| Carcinoma | 1 | 2007 | 322 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1006 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 139 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4822 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 336 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2002 | 34 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2007 | 447 | 0.050 |
Why?
|
| Genomics | 1 | 2011 | 1676 | 0.050 |
Why?
|
| Base Sequence | 2 | 2004 | 3170 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2003 | 188 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 1701 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3475 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2002 | 52 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2002 | 73 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 897 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2902 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2002 | 145 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 486 | 0.040 |
Why?
|
| Live Birth | 1 | 2021 | 70 | 0.040 |
Why?
|
| CD24 Antigen | 2 | 2013 | 32 | 0.040 |
Why?
|
| Integrin beta1 | 2 | 2013 | 56 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 626 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 190 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2002 | 343 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 991 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 483 | 0.040 |
Why?
|
| Rats, Inbred WF | 3 | 2007 | 21 | 0.040 |
Why?
|
| Squalene | 1 | 2019 | 25 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 1302 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 31 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1720 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 789 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 562 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 217 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 191 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 1326 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 20 | 0.040 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 184 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 330 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 1675 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 390 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 225 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 444 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 730 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 550 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 551 | 0.030 |
Why?
|
| Pregnancy, Animal | 2 | 2010 | 75 | 0.030 |
Why?
|
| Genotype | 1 | 2002 | 2807 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 102 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2005 | 2704 | 0.030 |
Why?
|
| Methylnitrosourea | 2 | 2007 | 18 | 0.030 |
Why?
|
| Aurora Kinases | 2 | 2007 | 28 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 690 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 7212 | 0.030 |
Why?
|
| Aurora Kinase A | 2 | 2007 | 38 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1070 | 0.030 |
Why?
|
| Vaccination | 1 | 2019 | 1011 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 400 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 120 | 0.030 |
Why?
|
| Cyclin D1 | 2 | 2005 | 123 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2015 | 4899 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 232 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2014 | 143 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 143 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2019 | 695 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 433 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 433 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 63 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 300 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 247 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 201 | 0.020 |
Why?
|
| Biomarkers | 2 | 2013 | 3426 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 907 | 0.020 |
Why?
|
| Lung | 1 | 2019 | 1557 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 791 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 577 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 717 | 0.020 |
Why?
|
| Galactosides | 1 | 2011 | 11 | 0.020 |
Why?
|
| Claudins | 1 | 2011 | 31 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 369 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 250 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 971 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 90 | 0.020 |
Why?
|
| Risk Factors | 1 | 2005 | 11101 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 1910 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 188 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 693 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 542 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 438 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 317 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1788 | 0.020 |
Why?
|
| Metaphase | 1 | 2008 | 35 | 0.020 |
Why?
|
| Anaphase | 1 | 2008 | 13 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 398 | 0.020 |
Why?
|
| Chromatids | 1 | 2008 | 41 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 70 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2008 | 45 | 0.020 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 46 | 0.020 |
Why?
|
| Tetracycline | 1 | 2008 | 80 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 226 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 397 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 21746 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 866 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 61 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 104 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2007 | 83 | 0.020 |
Why?
|
| Polyploidy | 1 | 2007 | 19 | 0.020 |
Why?
|
| Karyotyping | 1 | 2007 | 324 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1310 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1315 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 560 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 29409 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 464 | 0.020 |
Why?
|
| United States | 1 | 2002 | 11687 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 129 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 119 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2836 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1022 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 31950 | 0.010 |
Why?
|
| Menopause | 1 | 2005 | 88 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 2005 | 88 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 59 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2007 | 407 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1350 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 951 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 5182 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 118 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2005 | 351 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2002 | 15 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 508 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 60 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 95 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 150 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2002 | 105 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 616 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 472 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 905 | 0.010 |
Why?
|
| Male | 3 | 2016 | 65904 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1614 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 610 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9890 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 1629 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2781 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 1045 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3967 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2002 | 825 | 0.010 |
Why?
|